157 related articles for article (PubMed ID: 35646536)
1. Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning.
Liang D; Yu C; Ma Z; Yang X; Li Z; Dong X; Qin X; Du L; Li M
Acta Pharm Sin B; 2022 May; 12(5):2429-2442. PubMed ID: 35646536
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of new parbendazole derivatives for the treatment of HNSCC.
Liang D; Yu C; Ma Z; Hu M; Wang J; Dong X; Du L; Li M
Eur J Med Chem; 2022 Aug; 238():114450. PubMed ID: 35576703
[TBL] [Abstract][Full Text] [Related]
3. Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression.
Wei GG; Gao L; Tang ZY; Lin P; Liang LB; Zeng JJ; Chen G; Zhang LC
Pathol Res Pract; 2019 Jun; 215(6):152378. PubMed ID: 30871913
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential core genes and pathways predicting pathogenesis in head and neck squamous cell carcinoma.
Wang M; Zhong B; Li M; Wang Y; Yang H; Du K
Biosci Rep; 2021 May; 41(5):. PubMed ID: 33982750
[TBL] [Abstract][Full Text] [Related]
5. HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma.
Wu X; Li J; Yan T; Ke X; Li X; Zhu Y; Yang J; Li Z
Cancer Cell Int; 2021 Jul; 21(1):393. PubMed ID: 34303375
[TBL] [Abstract][Full Text] [Related]
6. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
Zhang F; Li Y; Zhang H; Huang E; Gao L; Luo W; Wei Q; Fan J; Song D; Liao J; Zou Y; Liu F; Liu J; Huang J; Guo D; Ma C; Hu X; Li L; Qu X; Chen L; Yu X; Zhang Z; Wu T; Luu HH; Haydon RC; Song J; He TC; Ji P
Oncotarget; 2017 Feb; 8(8):12968-12982. PubMed ID: 28099902
[TBL] [Abstract][Full Text] [Related]
7. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
Bayraktar A; Li X; Kim W; Zhang C; Turkez H; Shoaie S; Mardinoglu A
J Transl Med; 2023 May; 21(1):332. PubMed ID: 37210557
[TBL] [Abstract][Full Text] [Related]
8. The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer.
Florio R; Veschi S; di Giacomo V; Pagotto S; Carradori S; Verginelli F; Cirilli R; Casulli A; Grassadonia A; Tinari N; Cataldi A; Amoroso R; Cama A; De Lellis L
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31861153
[TBL] [Abstract][Full Text] [Related]
9. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.
Qiang W; Dai Y; Xing X; Sun X
Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
11. Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma.
Li P; Bian XY; Chen Q; Yao XF; Wang XD; Zhang WC; Tao YJ; Jin R; Zhang L
PLoS One; 2017; 12(5):e0177484. PubMed ID: 28494008
[TBL] [Abstract][Full Text] [Related]
12. A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma.
Sweeny L; Hartman YE; Zinn KR; Prudent JR; Marshall DJ; Shekhani MS; Rosenthal EL
Oral Oncol; 2013 Oct; 49(10):991-7. PubMed ID: 23920309
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma.
Qiu L; Tao A; Sun X; Liu F; Ge X; Li C
Oncol Res; 2023; 31(5):715-752. PubMed ID: 37547764
[TBL] [Abstract][Full Text] [Related]
14. The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma.
Li J; Chen W; Luo L; Liao L; Deng X; Wang Y
Aging (Albany NY); 2020 Nov; 13(1):769-781. PubMed ID: 33257597
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor modulates proliferation, cell cycle, and apoptotic activity in head and neck cancer cell lines.
Utispan K; Koontongkaew S
J Dent Sci; 2021 Jan; 16(1):342-348. PubMed ID: 33384818
[TBL] [Abstract][Full Text] [Related]
16. Binding of parbendazole to tubulin and its influence on microtubules in tissue-culture cells as revealed by immunofluorescence microscopy.
Havercroft JC; Quinlan RA; Gull K
J Cell Sci; 1981 Jun; 49():195-204. PubMed ID: 7031071
[TBL] [Abstract][Full Text] [Related]
17. HSP90AB1 Promotes the Proliferation, Migration, and Glycolysis of Head and Neck Squamous Cell Carcinoma.
Zhang H; Yin X; Zhang X; Zhou M; Xu W; Wei Z; Song C; Han S; Han W
Technol Cancer Res Treat; 2022; 21():15330338221118202. PubMed ID: 35929142
[No Abstract] [Full Text] [Related]
18. HDAC inhibitors suppress the proliferation, migration and invasiveness of human head and neck squamous cell carcinoma cells via p63‑mediated tight junction molecules and p21‑mediated growth arrest.
Kakiuchi A; Kakuki T; Ohwada K; Kurose M; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Kohno T; Himi T; Takano KI; Kojima T
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649777
[TBL] [Abstract][Full Text] [Related]
19. Targeting mTOR by CZ415 Inhibits Head and Neck Squamous Cell Carcinoma Cells.
Xie J; Li Q; Ding X; Gao Y
Cell Physiol Biochem; 2018; 46(2):676-686. PubMed ID: 29621758
[TBL] [Abstract][Full Text] [Related]
20. Palbociclib-based high-throughput combination drug screening identifies synergistic therapeutic options in HPV-negative head and neck squamous cell carcinoma.
Gu Z; Shi C; Li J; Han Y; Sun B; Zhang W; Wu J; Zhou G; Ye W; Li J; Zhang Z; Zhou R
BMC Med; 2022 May; 20(1):175. PubMed ID: 35546399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
